GLP-1 drugs show promise in reducing addiction, study finds
Baltimore, MD – According to The Baltimore Sun, a groundbreaking study has revealed that GLP-1 drugs, commonly prescribed for diabetes and obesity, hold significant promise in mitigating addiction to various substances. Published on March 4, 2026, by researchers at Washington University in St. Louis, the research examined data from 600,000 veterans diagnosed with type 2 … Read more